Evidence map›Paper›PMID 39051875›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2024

Leadless pacemaker implantation via the internal jugular vein.

Nadine Molitor, Shmaila Saleem-Talib, Hemanth Ramanna, Daniel Hofer, Alexander Breitenstein, Jan Steffel

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Jugular Journeys: A Novel Approach for AVEIR Leadless Pacemaker Implantation.Pacing and clinical electrophysiology : PACE · 2026
    Article
  7. Article
  8. Comparison of transjugular and transfemoral approaches for leadless pacemaker implantation in Asian patients: an exploratory study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  9. Article
  10. Initial experience utilizing the right internal jugular vein access for implantation of retrievable leadless pacemakers: safety, efficacy, and efficiency.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  11. Micra leadless pacemaker revisions: incidence, characteristics, and outcomes from a multicentre French cohort.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  12. [Leadless cardiac pacemaker : Overview, tips, and tricks].Herzschrittmachertherapie & Elektrophysiologie · 2025
    Review
  13. Article
  14. Article
  15. Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement.Structural heart : the journal of the Heart Team · 2025
    Review
  16. Review
  17. Novel approach to pulmonary vein isolation ablationWorld journal of cardiology · 2025
    Article
  18. Leadless pacing: a comprehensive review.European heart journal · 2025
    Review
  19. Evolution of leadless pacemaker technology.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  20. Leadless pacing in young patients.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadine MolitorDepartment of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.ORCID 0000-0003-2544-7354
Shmaila Saleem-TalibDepartment of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands.ORCID 0000-0001-5053-3284
Hemanth RamannaDepartment of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands.ORCID 0009-0004-0441-0506
Daniel HoferDepartment of Cardiology, Triemlispial, Zurich, Switzerland.ORCID 0000-0001-8164-6329
Alexander BreitensteinDepartment of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.ORCID 0000-0002-4440-2947
Jan SteffelHeartClinic, Hirslanden Clinic, Zurich, Switzerland.ORCID 0000-0002-1477-9153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsLeadless pacemaker therapy was introduced to overcome lead- and pocket-related complications in conventional transvenous pacemaker systems. Implantation via the femoral vein, however, may not always be feasible. The aim of this study was to evaluate leadless pacemaker implantation using a jugular vein approach and compare it to the standard implantation via the femoral vein. METHODS AND

resultsThe records of the first consecutive 100 patients undergoing Micra™ leadless pacemaker implantation via the right internal jugular vein from two centres were included in this study. Peri-procedural safety and efficacy of the jugular approach were compared to the first 100 patients using a femoral implantation approach at the University Hospital Zurich. One hundred patients underwent successful implantation of a leadless pacemaker via the internal jugular vein (mean age, 81.18 ± 8.29, 60% males). Mean procedure time was 35.63 ± 10.29 min with a mean fluoroscopy time of 4.66 ± 5.16 min. The device was positioned at the inferior septum in 25 patients, at the high septum in 24 patients, and mid-septum in 51 patients. The mean pacing threshold was 0.56 ± 0.35 V at 0.24 ms pulse width with a sensed amplitude of 10.0 ± 4.4 mV. At follow-up, electrical parameters remained stable in all patients. Compared with femoral implantation, patients undergoing the jugular approach were of similar age and had similar comorbidities. Mean procedure (48.9 ± 21.0 min) and fluoroscopy times (7.7 ± 7.8 min, both P < 0.01) were shorter compared to the femoral approach. Electrical parameters were similar between the two approaches. There were only two complications during jugular veinous implantations (1 pericardial effusion and 1 dislocation), compared to 16 complications using the femoral approach (1 pericardial effusion, 2 femoral artery injuries, and 13 major groin haematomas).

conclusionThe jugular approach may represent a safe and efficient alternative to femoral implantation of the Micra leadless pacemaker.

Indexed as

Cardiac Pacing, ArtificialFemoral VeinJugular VeinsPacemaker, ArtificialAgedAged, 80 and overArrhythmias, CardiacEquipment DesignFemaleHumansMaleProsthesis ImplantationRetrospective StudiesTime FactorsTreatment OutcomeJugular veinLeadless pacingPacemaker

Identifiers

PMID39051875
PMCPMC11304476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.